Regulatory mechanism of homologous recombination by USP7-CRL4Cdt2 axis
Implementing Organization
Principal Investigator
Dr. Mohd Ashraf Dar
sher-E-Kashmir University, Jammu & Kashmir Of Agriculture sciences & Technology
About
This proposal aims to explore the functional link between USP7 deubiquitinase and CRL4Cdt2 E3 ubiquitin ligase, and extend its role in regulating homologous recombination repair (HR). USP7 is a deubiquitinating enzyme that stabilizes substrates by protecting them from ubiquitin-mediated degradation. CRL4Cdt2 promotes ubiquitin-mediated degradation of substrates during the cell cycle and accumulates at double-stranded break sites after DNA damage. The E3 ubiquitin ligases RNF8 and RNF168 are responsible for H2AX ubiquitination at damaged sites, which triggers the recruitment of 53BP1 and RAP80/BRCA1 complex to DSB sites. USP7 has been recently implicated in the promotion of HR, but how it promotes HR remains unclear. Based on existing literature and preliminary data, the study hypothesizes that the USP7 and CRL4Cdt2 complex form a novel axis with a regulatory role in HR. Experiments suggest that USP7 deubiquitinase activity is required for the stability of the functional CRL4Cdt2 complex. Objectives include establishing the functional link between USP7 and CRL4Cdt2, determining the effect of inactivation of USP7 on the CRL4Cdt2 complex under basal and DNA-damaging conditions, and evaluating the role of the USP7-CRL4Cdt2 axis in HR using I-SecI-based HR assay. The study aims to implicate this novel axis of the USP7-CR4Cdt2 in HR, as both USP7 and CRL4Cdt2 are druggable enzymes. By understanding the role of the USP7-CR4Cdt2 novel axis in HR, this study could serve as a foundation for targeting USP7 and CRL4Cdt2 and disrupting the HR pathway as a therapeutic strategy for various malignancies.
Source
Source
Anusandhan National Research Foundation/Science and Engineering Research Board (SERB), DST 2023-24
Science and Engineering Research Board (SERB), New Delhi
Anusandhan National Research Foundation (ANRF)
Quick Information
Area of Research
Life Sciences & Biotechnology
Start Year
2024
End Year
2027
Sanction Amount
₹ 63.91 L
Status
Ongoing
Contact
ashrafdar@kashmiruniversity.ac.in
Output
No. of Research Paper
00
Technologies (If Any)
00
No. of PhD Produced
00
No. of Patents
Filed :00
Grant :00
Disclaimer:
Information available on this portal is sourced from various organizations and is provided for informational purposes only. Users are advised to verify details from the respective official sources.
Please enter your details
Please provide your name and email to continue. Your details are saved in this browser for future use.
Latest Updates
Loading…
⚠️
You are leaving this website
You are about to be redirected to an external website that is not operated by
India Science, Technology & Innovation (ISTI) Portal.